Grifols is a global healthcare company dedicated to improving the health and well-being of people around the world.
Established in Barcelona, Spain in 1940, we are an industry leader in the production of plasma-derived medicines, with 20,000 employees across 30 countries.
As our business continues to grow, we remain committed to a long-term, sustainable and responsible vision.
Commitment to patients
The patients we serve around the world are able to lead better lives thanks to plasma-derived medicines and donors. Patients inspire the work we do every day.
July 4, 2019
Grifols announces FDA approval of Xembify®, 20% subcutaneous immunoglobulin for primary immunodeficiencies
July 3, 2019
Grifols selected to build its first intravenous solutions manufacturing line in Africa
Our business is organized into four divisions: Bioscience, Diagnostic, Hospital and Bio Supplies.
We are committed to a long-term vision that creates a sustainable, positive impact on the communities in which we operate.
Since the foundation of Grifols, our on-going innovation has helped shape industry standards in the plasma medicines sector.
Do you want to know more about one of the leading healthcare companies? Here you will find all the information about Grifols and our commitment to improving the health and well-being of people around world.
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?